Coalition Raises $10M in Series A Funding
Coalition, Inc., a San Francisco, CA-based technology-enabled cyber insurance solution, raised $10m in Series A funding.
Coalition, Inc., a San Francisco, CA-based technology-enabled cyber insurance solution, raised $10m in Series A funding.
Linius Technologies Limited (ASX: LNU), a Melbourne, Australia-based provider of a video virtualization platform, raised A$10m in placement of shares and options.
Lean Media, a Cheterfield, MO-based audience-first programmatic media company serving the agriculture industry and businesses targeting rural audiences, closed $500K in seed funding.
Bring!, a Zurich, Switzerland-based provider of a shopping list platform, received USD$2.5m in funding.
Global investment in fintech ventures reached the all-time high in 2017, driven by a surge in funding for startups in the United States, United Kingdom and India.
Survaider, a Chennai, India-based SaaS based Customer Experience Management platform, raised $500k in Pre Series A funding.
HabX, a Paris, France-based digital home design startup, raised €9.5m in funding.
CounterFlow AI, a Charlottesville, Va.-based cybersecurity startup, raised $2.7m in seed funding.
Pirs Capital, a fintech alternative lender specializing in Merchant Cash Advances, secured an undisclosed financing in the form of revolving credit.
Joieful, a New Orleans, L.A.-based experiences platform for visitors, groups, and locals to the Crescent City, is raising $1.2m in a Series A funding round.
FreeAgent CRM, a Saratoga, CA-based CRM for small businesses to grow sales, raised $5.6M in seed financing.
Boost Biomes, a San Francisco, CA-based developer of microbiome-based products, closed a $2.05M seed funding round.
Turner Imaging Systems, an Orem, Utah-based developer of the Smart-C battery-powered mini C-arm, closed a seed funding round of undisclosed amount.
Seneca Systems, a Redwood City, CA-based provider of purpose-built software for government workers, secured $3.5M in seed financing.
Generation Bio, a Cambridge, Mass.-based developer of genetic medicines, closed a $100m Series B financing.